.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Julphar
Argus Health
Cipla
Farmers Insurance
US Army
McKesson
UBS
Queensland Health
Healthtrust

Generated: September 19, 2017

DrugPatentWatch Database Preview

SANCTURA XR Drug Profile

« Back to Dashboard

Which patents cover Sanctura Xr, and when can generic versions of Sanctura Xr launch?

Sanctura Xr is a drug marketed by Allergan and is included in one NDA. There are five patents protecting this drug and one Paragraph IV challenge.

This drug has thirteen patent family members in eleven countries.

The generic ingredient in SANCTURA XR is trospium chloride. There are sixteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the trospium chloride profile page.

Summary for Tradename: SANCTURA XR

Patents:5
Applicants:1
NDAs:1
Bulk Api Vendors: see list30
Clinical Trials: see list4
Patent Applications: see list596
Drug Prices:see details
DailyMed Link:SANCTURA XR at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan
SANCTURA XR
trospium chloride
CAPSULE, EXTENDED RELEASE;ORAL022103-001Aug 3, 2007DISCNYesNo► Subscribe► SubscribeY ► Subscribe
Allergan
SANCTURA XR
trospium chloride
CAPSULE, EXTENDED RELEASE;ORAL022103-001Aug 3, 2007DISCNYesNo► Subscribe► Subscribe ► Subscribe
Allergan
SANCTURA XR
trospium chloride
CAPSULE, EXTENDED RELEASE;ORAL022103-001Aug 3, 2007DISCNYesNo► Subscribe► Subscribe ► Subscribe
Allergan
SANCTURA XR
trospium chloride
CAPSULE, EXTENDED RELEASE;ORAL022103-001Aug 3, 2007DISCNYesNo► Subscribe► Subscribe ► Subscribe
Allergan
SANCTURA XR
trospium chloride
CAPSULE, EXTENDED RELEASE;ORAL022103-001Aug 3, 2007DISCNYesNo► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: SANCTURA XR

Drugname Dosage Strength RLD Submissiondate
trospium chlorideExtended-release Capsules60 mgSanctura XR3/2/2009

Premature patent expiration for: SANCTURA XR

Expiration due to failure to pay maintenance fee

Patent Number Tradename Expiration Date
► Subscribe
SANCTURA XR
► Subscribe

International Patent Family for Tradename: SANCTURA XR

Country Document Number Estimated Expiration
European Patent Office2210605► Subscribe
Japan5783489► Subscribe
Australia2004289223► Subscribe
Japan2012144577► Subscribe
Hong Kong1088547► Subscribe
World Intellectual Property Organization (WIPO)2005046684► Subscribe
Portugal2210605► Subscribe
Germany602004030931► Subscribe
Denmark2210605► Subscribe
Austria493981► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
US Army
Colorcon
Queensland Health
Cerilliant
Express Scripts
Julphar
Federal Trade Commission
Chubb
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot